{"id":"W3194914839","doi":"10.1093/eurheartj/ehab408","title":"Low-dose rivaroxaban plus aspirin in older patients with peripheral artery disease undergoing acute limb revascularization: insights from the VOYAGER PAD trial","year":2021,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Peripheral Artery Disease Management","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Intégré de Santé et de Services Sociaux des Laurentides; Hamilton Health Sciences; McGill University; Centre intégré de santé et de services sociaux de Chaudière-Appalaches; McMaster University; Population Health Research Institute","funders":"Janssen Research and Development; Bayer","keywords":"Medicine; Rivaroxaban; Aspirin; Arterial disease; Revascularization; Peripheral; Critical limb ischemia; Cardiology; Vascular disease; Internal medicine; Surgery; Myocardial infarction; Warfarin; Atrial fibrillation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003108234,0.0007579831,0.002139295,0.0002365367,0.0001633088,0.001190881,0.0003733652,0.0006979779,0.002083107],"category_scores_gemma":[0.00292663,0.0001638131,0.001684647,0.0004169589,0.0002808098,0.0004648578,0.0005060124,0.001277688,0.0003611702],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002978928,"about_ca_system_score_gemma":0.0005768731,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002741832,"about_ca_topic_score_gemma":0.0007557876,"domain_scores_codex":[0.9985568,0.0009859155,0.00009350168,0.0001142009,0.0001259973,0.0001236855],"domain_scores_gemma":[0.9988278,0.0003783255,0.0003403593,0.0000854015,0.00008607632,0.0002821446],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7800519,0.004297367,0.04782791,0.007061106,0.01808322,0.000557083,0.0002716327,0.001863147,0.005282138,0.001367658,0.01204759,0.1212892],"study_design_scores_gemma":[0.6946801,0.0744847,0.1882624,0.00142188,0.01828195,0.0009595223,0.0002073955,0.002223437,0.0009133264,0.003502908,0.01494779,0.0001145307],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9347495,0.05094551,0.0008525633,0.002711599,0.0005795934,0.001065868,0.003473829,0.00007260435,0.005548963],"genre_scores_gemma":[0.9757144,0.01255649,0.001301781,0.001894617,0.001370713,0.00141057,0.004540763,0.00002401827,0.001186532],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003108234,"threshold_uncertainty_score":0.01643813,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01642969878704749,"score_gpt":0.2457621718293568,"score_spread":0.2293324730423092,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}